Juxtapid (Royalty Interest) Overview

  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Financing Rounds
  • 1

Juxtapid (Royalty Interest) General Information

Description

A portion of royalty interest in Juxtapid. Juxtapid is an oral therapy for the treatment of adults with homozygous familial hypercholesterolemia. Its generic name is Lomitapide.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Philadelphia, PA 19104
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Juxtapid (Royalty Interest) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Juxtapid (Royalty Interest)‘s full profile, request access.

Request a free trial

Juxtapid (Royalty Interest) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Juxtapid (Royalty Interest)‘s full profile, request access.

Request a free trial